Clinical Trials Search at Vanderbilt-Ingram Cancer Center

Filter By:

Search by Keyword (disease, investigator, treatment name):

A Registry Study to Evaluate the Survival and Long-Term Safety of Subjects Who Previously Received Talimogene Laherparepvec in Amgen or BioVEX-Sponsored Clinical Trials

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Johnson, Douglas

NCTID: NCT02173171

Protocol No: VICCMEL14103

Wren Melanoma Study

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Kauffmann, Rondi

NCTID: NCT03267381

Protocol No: VICCMEL1783

Investigating Immune Responses in Patients with Advanced Melanoma Treated with Immune-Based Therapy

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Irish, Jonathan

NCTID:

Protocol No: VICCMEL15148

Melanoma, Pigmented Lesion and Cutaneous Malignancy Tissue and Bio-Specimen Repository

Multiple Cancer Types

Disease Sites: Dermatologic, Melanoma

Phase: N/A

Investigator: Kauffmann, Rondi

NCTID:

Protocol No: VICCMEL0287

Storage and Research Use of Human Biospecimens from Melanoma Patients and Clinical Testing for the Assignment of Therapy

Melanoma

Disease Sites: Melanoma

Phase: N/A

Investigator: Johnson, Douglas

NCTID: NCT01205815

Protocol No: VICCMEL09109

Clinical Trial Flowcharts
for Referring Physicians

Clinical Trial Flowcharts
for VICC Staff (VUNetID required)